Study 309/Keynote-775: A Randomized, Phase 3 Study to Compare the Efficacy and Safety of Lenvatinib with Pembrolizumab vs Treatment of Physician’s Choice in Advanced Endometrial Cancer

Description

Recorded Live: May 10, 2022

Presenter
Vicky Makker, MD
USA

Summary


Availability:	On-Demand


Cost:	FREE

Create Account

Recommended

Multidisciplinary Approach to Treating Advanced Endometrial Cancer

FREE

Endometrial Cancer Tumor Board: Matching the right therapy to the right patient

FREE

Treatment Options for Platinum Resistant Ovarian Cancer

FREE

Multidisciplinary Approach to Treating Advanced Endometrial Cancer - Webinar

FREE

Second-Line Treatment Options for Patients with Recurrent Cervical Cancer. Review of Current Treatment and Future Directions

FREE

Second-Line Treatment Options for Patients with Recurrent Cervical Cancer. Review of Current Treatment and Future Directions - Webinar

FREE

Treatment Options for Platinum Resistant Ovarian Cancer - Webinar

FREE

Radical Hysterectomy - Surgical Film Festival - Webinar

$0.00 - $50.00

Master Class: Managing Toxicities with TKIs in combination with Checkpoint Inhibitors in Endometrial Cancer

FREE